These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35717480)

  • 1. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study.
    Lim SY; May CB; Johnson PN; Miller JL
    Pediatr Res; 2023 Feb; 93(3):696-700. PubMed ID: 35717480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
    Yu CZ; Myers SR; Faldasz JD
    Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
    DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
    Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental pharmacokinetics of propylene glycol in preterm and term neonates.
    De Cock RF; Knibbe CA; Kulo A; de Hoon J; Verbesselt R; Danhof M; Allegaert K
    Br J Clin Pharmacol; 2013 Jan; 75(1):162-71. PubMed ID: 22536830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.
    Anderson BJ; van Lingen RA; Hansen TG; Lin YC; Holford NH
    Anesthesiology; 2002 Jun; 96(6):1336-45. PubMed ID: 12170045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Timing and Dosing of Caffeine Citrate in Preterm Neonates for the Prevention of Bronchopulmonary Dysplasia.
    Shenk EE; Bondi DS; Pellerite MM; Sriram S
    J Pediatr Pharmacol Ther; 2018; 23(2):139-145. PubMed ID: 29720916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.
    Rengelshausen J; Beedgen B; Tsamouranis K; Mikus G; Walter-Sack I; Haefeli WE; Linderkamp O
    Eur J Clin Pharmacol; 2006 Sep; 62(9):773-7. PubMed ID: 16865390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
    van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
    Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial.
    Starr MC; Griffin R; Gist KM; Segar JL; Raina R; Guillet R; Nesargi S; Menon S; Anderson N; Askenazi DJ; Selewski DT;
    JAMA Netw Open; 2022 Dec; 5(12):e2248826. PubMed ID: 36580332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Fike CD; Avachat C; Birnbaum AK; Aschner JL; Sherwin CM
    Paediatr Drugs; 2023 Jan; 25(1):87-96. PubMed ID: 36316628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic Study.
    Wu Y; Völler S; Flint RB; Simons SHP; Allegaert K; Fellman V; Knibbe CAJ
    Clin Pharmacokinet; 2022 Mar; 61(3):401-412. PubMed ID: 34773609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine metabolism in premature infants.
    al-Alaiyan S; al-Rawithi S; Raines D; Yusuf A; Legayada E; Shoukri MM; el-Yazigi A
    J Clin Pharmacol; 2001 Jun; 41(6):620-7. PubMed ID: 11402630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily gentamicin dosing in newborn infants.
    Lundergan FS; Glasscock GF; Kim EH; Cohen RS
    Pediatrics; 1999 Jun; 103(6 Pt 1):1228-34. PubMed ID: 10353934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioavailability and maturing clearance of doxapram in preterm infants.
    Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
    Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.